About the Product

Description


Defziff 36 Tablet containing Deflazacort is used for the management of inflammatory, allergic, and autoimmune conditions under medical supervision. It helps reduce inflammation and supports immune response control.

Deflazacort works as a corticosteroid that suppresses inflammatory reactions and modulates immune system activity, thereby helping relieve swelling, pain, and allergic symptoms.

The tablet is widely prescribed in general medicine and specialty care practice for inflammation and immune-related disorder management, leading to consistent prescription demand.

With increasing prevalence of inflammatory and autoimmune disorders, this product offers strong business potential for retailers and distributors. Its established corticosteroid action, broad therapeutic relevance, and steady market demand make it a reliable product for growth in the anti-inflammatory care segment.

Some patients may experience increased appetite, weight gain, mood changes, stomach irritation, elevated blood sugar, or fluid retention. Rarely, long-term use may cause osteoporosis, weakened immunity, adrenal suppression, or vision-related problems.

Defziff 36 Tablet is indicated for inflammatory disorders, allergic conditions, asthma, autoimmune diseases, muscular disorders, and certain rheumatic conditions. It helps reduce inflammation, swelling, pain, and immune-related symptoms.

This medicine should be used strictly under medical supervision. Do not stop the medicine abruptly, especially after prolonged use, as gradual dose reduction may be required. Regular monitoring may be needed during long-term therapy.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Defziff 36 Tablet in the PCD pharma franchise market?

Defziff 36 Tablet, containing Deflazacort 36mg, has strong demand in the steroid and anti-inflammatory segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on inflammation, allergy, and autoimmune care portfolios.

Why should medical distributors include Defziff 36 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for corticosteroid therapy used in severe allergies, asthma exacerbations, autoimmune disorders, skin diseases, and inflammatory conditions. Deflazacort provides effective anti-inflammatory action with relatively better tolerability, strengthening a comprehensive steroid product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Defziff 36 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Defziff 36 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Defziff 36 Tablet distribution?

Wholesalers and medical agencies benefit from strong hospital prescription demand, chronic and acute therapy usage, reliable supply chain support, and good margins when partnering for Defziff 36 Tablet distribution.

How can I become a distributor or franchise partner for Defziff 36 Tablet?

Medical distributors, stockists, and wholesalers interested in Defziff 36 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.